Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Tevogen Bio Holdings Inc. before investing.

In this article, we go over a few key elements for understanding Tevogen Bio Holdings Inc.’s stock price such as:

• Tevogen Bio Holdings Inc.’s current stock price and volume
• Why Tevogen Bio Holdings Inc.’s stock price changed recently
• Upgrades and downgrades for TVGN from analysts
• TVGN’s stock price momentum as measured by its relative strength

About Tevogen Bio Holdings Inc. (TVGN)

Before we jump into Tevogen Bio Holdings Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients. It is also developing TVGN 920 for treating cervical cancer; TVGN 960 for treating oropharyngeal cancer; TVGN 601 for treating MS; and TVGN 930 for treating EBV-associated lymphomas. The company was founded in 2020 and is headquartered in Warren, New Jersey.

Want to learn more about Tevogen Bio Holdings Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Tevogen Bio Holdings Inc..

Tevogen Bio Holdings Inc.’s Stock Price as of Market Close

As of April 29, 2025, 12:31 PM, CST, Tevogen Bio Holdings Inc.’s stock price was $1.045.

Tevogen Bio Holdings Inc. is up 11.48% from its previous closing price of $0.937.

During the last market session, Tevogen Bio Holdings Inc.’s stock traded between $0.960 and $1.100. Currently, there are approximately 106.69 million shares outstanding for Tevogen Bio Holdings Inc..

Tevogen Bio Holdings Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Tevogen Bio Holdings Inc. Stock Price History

Tevogen Bio Holdings Inc.’s (TVGN) price is currently down 3.24% so far this month.

During the month of April, Tevogen Bio Holdings Inc.’s stock price has reached a high of $1.250 and a low of $0.890.

Over the last year, Tevogen Bio Holdings Inc. has hit prices as high as $3.090 and as low as $0.256. Year to date, Tevogen Bio Holdings Inc.’s stock is up 1.46%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Tevogen Bio Holdings Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 28, 2025, there were analysts who downgraded Tevogen Bio Holdings Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Tevogen Bio Holdings Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Tevogen Bio Holdings Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Tevogen Bio Holdings Inc. (TVGN) by visiting AAII Stock Evaluator.

Relative Price Strength of Tevogen Bio Holdings Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 28, 2025, Tevogen Bio Holdings Inc. has a weighted four-quarter relative price strength of 23.95%, which translates to a Momentum Score of 95 and is considered to be Very Strong.

Want to learn more about how Tevogen Bio Holdings Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Tevogen Bio Holdings Inc. Stock Price: Bottom Line

As of April 29, 2025, Tevogen Bio Holdings Inc.’s stock price is $1.045, which is up 11.48% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Tevogen Bio Holdings Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.